ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China
· Delayed Price · Currency is CNY 38.80
+0.50 (1.31%)
Mar 10, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Operating Revenue | 741.34 | 451.08 | 431.32 | 386.88 | 369.3 | Upgrade
|
| Other Revenue | - | 4.99 | 3.7 | 8.84 | 17.23 | Upgrade
|
| Revenue | 741.34 | 456.07 | 435.02 | 395.72 | 386.53 | Upgrade
|
| Revenue Growth (YoY) | 62.55% | 4.84% | 9.93% | 2.38% | 2.05% | Upgrade
|
| Cost of Revenue | - | 201.61 | 163.38 | 142.39 | 110.67 | Upgrade
|
| Gross Profit | 741.34 | 254.46 | 271.64 | 253.33 | 275.86 | Upgrade
|
| Selling, General & Admin | - | 127.76 | 161.01 | 157.82 | 190.73 | Upgrade
|
| Research & Development | - | 49.17 | 29.05 | 23.29 | 13.75 | Upgrade
|
| Other Operating Expenses | 540.5 | 3.11 | 1.24 | 4.72 | 4.8 | Upgrade
|
| Operating Expenses | 540.5 | 188.4 | 194.37 | 188.29 | 210.14 | Upgrade
|
| Operating Income | 200.84 | 66.06 | 77.27 | 65.04 | 65.71 | Upgrade
|
| Interest Expense | - | -11.8 | -9.08 | -3.24 | -0.17 | Upgrade
|
| Interest & Investment Income | - | 3.75 | 3.92 | 4.57 | 4.2 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.78 | 0.5 | 3 | -0.67 | Upgrade
|
| Other Non Operating Income (Expenses) | -12.81 | -0.21 | -0.29 | -1.55 | -0.5 | Upgrade
|
| EBT Excluding Unusual Items | 188.03 | 58.57 | 72.33 | 67.82 | 68.58 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.16 | -1.42 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.59 | -0.91 | -0.39 | -4.89 | Upgrade
|
| Other Unusual Items | - | 3.37 | 10.12 | 4.93 | 6.8 | Upgrade
|
| Pretax Income | 188.03 | 61.51 | 80.12 | 72.36 | 70.49 | Upgrade
|
| Income Tax Expense | 22.21 | 11.67 | 9.8 | 7.88 | 9.24 | Upgrade
|
| Earnings From Continuing Operations | 165.82 | 49.84 | 70.32 | 64.48 | 61.25 | Upgrade
|
| Minority Interest in Earnings | - | 0.19 | 0.01 | - | - | Upgrade
|
| Net Income | 165.82 | 50.02 | 70.34 | 64.48 | 61.25 | Upgrade
|
| Net Income to Common | 165.82 | 50.02 | 70.34 | 64.48 | 61.25 | Upgrade
|
| Net Income Growth | 231.49% | -28.88% | 9.08% | 5.28% | 2.09% | Upgrade
|
| Shares Outstanding (Basic) | 158 | 156 | 156 | 156 | 141 | Upgrade
|
| Shares Outstanding (Diluted) | 158 | 159 | 159 | 156 | 141 | Upgrade
|
| Shares Change (YoY) | -0.77% | 0.22% | 2.03% | 10.21% | 20.10% | Upgrade
|
| EPS (Basic) | 1.05 | 0.32 | 0.45 | 0.41 | 0.43 | Upgrade
|
| EPS (Diluted) | 1.05 | 0.31 | 0.44 | 0.41 | 0.43 | Upgrade
|
| EPS Growth | 234.08% | -29.04% | 6.90% | -4.47% | -14.99% | Upgrade
|
| Free Cash Flow | - | -222.2 | -193.2 | -40.23 | -11.81 | Upgrade
|
| Free Cash Flow Per Share | - | -1.40 | -1.22 | -0.26 | -0.08 | Upgrade
|
| Dividend Per Share | - | 0.100 | 0.143 | 0.128 | 0.153 | Upgrade
|
| Dividend Growth | - | -30.02% | 11.99% | -16.66% | - | Upgrade
|
| Gross Margin | 100.00% | 55.79% | 62.44% | 64.02% | 71.37% | Upgrade
|
| Operating Margin | 27.09% | 14.49% | 17.76% | 16.44% | 17.00% | Upgrade
|
| Profit Margin | 22.37% | 10.97% | 16.17% | 16.30% | 15.85% | Upgrade
|
| Free Cash Flow Margin | - | -48.72% | -44.41% | -10.17% | -3.06% | Upgrade
|
| EBITDA | 234.44 | 99.66 | 104.92 | 88.77 | 83.65 | Upgrade
|
| EBITDA Margin | 31.62% | 21.85% | 24.12% | 22.43% | 21.64% | Upgrade
|
| D&A For EBITDA | 33.59 | 33.59 | 27.65 | 23.72 | 17.94 | Upgrade
|
| EBIT | 200.84 | 66.06 | 77.27 | 65.04 | 65.71 | Upgrade
|
| EBIT Margin | 27.09% | 14.49% | 17.76% | 16.44% | 17.00% | Upgrade
|
| Effective Tax Rate | 11.81% | 18.98% | 12.23% | 10.89% | 13.10% | Upgrade
|
| Revenue as Reported | - | 456.07 | 435.02 | 395.72 | 386.53 | Upgrade
|
| Advertising Expenses | - | 1.92 | 0.5 | 0.09 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.